New radiation 'Seed' device takes on Hard-to-Treat head and neck cancer
NCT ID NCT05047094
First seen Dec 08, 2025 · Last updated May 24, 2026 · Updated 24 times
Summary
This study is for people with advanced head and neck cancer that has come back or spread. It tests a special device placed directly into the tumor that gives off a unique type of radiation (alpha rays) combined with an immunotherapy drug called pembrolizumab. The goal is to see if this combination can shrink tumors and help control the cancer. About 48 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sharett institute, Hadassah University Hospital - Ein-Kerem
RECRUITINGJerusalem, 91120, Israel
Contact
-
Sheba Medical Center
RECRUITINGRamat Gan, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tel-Aviv Medical Center
NOT_YET_RECRUITINGTel Aviv, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.